Zhongguo shiyan zhenduanxue, 2009 目的探讨前列腺特异性抗原（PSA）、PSA密度（PSAD）、游离PSA/总PSA比值（f/tPSA）在诊断早期前列腺癌（PCa）中的价值。方法对640例患者行前列腺穿刺活检,其中PSA0.15f ...
计国义 +4 more
doaj
[Research progress on prostate-specific membrane antigen ligand positron emission tomography imaging of prostate cancer]. [PDF]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2022 Li Y, Liu B, Yuan Y, Qin W.
europepmc +1 more source
Ki-67、C-erb-B2及nm23在前列腺癌中的表达及意义
Zhongguo shiyan zhenduanxue, 2010 目的探讨相关癌基因等在前列腺癌中表达的意义,从病理学角度了解前列腺癌的生物学特性。方法根据最新WHO分类标准（2002）及Gleason分级法进行组织学分级和对比性分析;应用免疫组织化学技术,观察增殖细胞核抗原Ki-67、原癌基因c-erbB-2、抑癌基因nm23在前列腺癌中的表达情况。结果近81.69%的患者在Gleason分级8分以上;Ki-67与组织学分级之间有显著性差异 ...
毕丽荣, 杨华, 刘仲祥, 王连有
doaj
[High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2022 Yang M +7 more
europepmc +1 more source
[Recent advances in antibody-drug conjugates for metastatic castration-resistant prostate cancer]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanXu J, Ma Y, Hu P, Yao J, Chen H, Ma Q.
europepmc +1 more source
Clinical application and progress of quantitative functional magnetic resonance imaging in prostate cancer. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021 Li M, Li W.
europepmc +1 more source
[Design, Synthesis, and Efficacy Evaluation of a Novel BRD4/HDAC Dual-Target Small-Molecule Inhibitor in Prostate Cancer]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanFeng S, Shao Y, Wu K, Yang W, Li X.
europepmc +1 more source
[Effect of dephosphorylation of tumor metastasis suppressor gene <i>LASS2</i> on vacuolar ATPase activity and invasiveness of prostate cancer]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanLiu Y +8 more
europepmc +1 more source
前列腺特异性膜抗原PET/CT对减少前列腺癌过度穿刺活检的应用价值
Zhongshan Daxue xuebao. Yixue kexue ban目的评估前列腺特异性膜抗原（PSMA）PET/CT在前列腺穿刺活检筛查中的应用效果，提出基于PSMA PET/CT检查的前列腺癌穿刺活检策略。方法回顾性分析2020年1月至2023年12月期间155例可疑前列腺癌患者穿刺活检前的PSMA PET/CT图像和临床病理资料。采用PRIMARY 评分作为PSMA PET/CT诊断前列腺癌的标准化评估方法，比较不同PRIMARY 评分筛选前列腺穿刺患者的活检阳性率、漏诊患者比例及避免活检患者比例。使用ROC曲线分析PSA及其衍生指标 ...
张继燊 +4 more
doaj